Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 2, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record70510 flagged findings
Reported transactions (Form 4)40since Jan 24, 2023 · and 7 other holdings
Corporate events (8-K)30since Aug 10, 2023
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-18share offering or dilution eventrecentOpen filing ↗“…pursuant to Section 13(a) of the Exchange Act. ¨ Item 3.02 Unregistered Sales of Equity Securities. Daré Bioscience, Inc.…”
- 2026-05-14share offering or dilution eventrecentOpen filing ↗“…financial statements. Taking into account these payments, we have received a cumulative total of approximately $9.0 million…”
+1 more passage from the same document
- “…into account these payments, we have received a cumulative total of approximately $9.0 million of the up to $10.0 million in…”
- 2026-05-14listing compliance noticerecentOpen filing ↗“…condensed consolidated financial statements and “Liquidity and Capital Resources–Capital Resources” below for additional…”
+1 more passage from the same document
- “…2025, we received a letter from the Nasdaq Office of General Counsel confirming that we had demonstrated compliance with the…”
- 2026-05-14capital return (buybacks/dividends)recentOpen filing ↗“…stock method. Under the treasury stock method, the exercise price of an option or warrant, the amount of compensation cost, if…”
- 2026-05-14merger or acquisition eventrecentOpen filing ↗“…of such products sold by the Company (but not by sublicensee) and a percentage of sublicense revenue related to such products. In…”
+1 more passage from the same document
- “…MBI, to secure the rights to develop a long-acting reversible contraception method, that a woman can turn on or off herself,…”
- 2026-05-07share offering or dilution eventrecentOpen filing ↗“…pursuant to Section 13(a) of the Exchange Act. ¨ Item 3.02 Unregistered Sales of Equity Securities. Daré Bioscience, Inc.…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
Listing notice in force
The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Oct 2, 2026).
Deadline: Mar 27, 2027
- minimum bid price · Nasdaq, rule 5550(a)(2) · notice of Sep 28, 2026 · pending · deadline Mar 27, 2027 (text and rule agree)
Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.
Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.
Reverse splits in 5 years
1 reverse split in 5 years (1:12 on Jul 1, 2024) · 1:12 cumulative
The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 705)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 6, 26DEF 14A ↗Shareholder meeting and votes
- Oct 2, 268-K ↗Current report · Listing notice (8-K 3.01)
- Oct 1, 268-K ↗Current report · Communication to the market
- Sep 23, 26PRE 14A ↗Shareholder meeting and votes
- Sep 11, 268-K ↗Current report · Bylaws or fiscal year change
- Sep 9, 268-K ↗Current report · Communication to the market
- Sep 4, 26424B3 ↗Securities offering
- Aug 28, 26SCHEDULE 13G ↗Passive stake · Lind Global Fund III LP · 5.7% · event on Aug 17, 26
- Aug 26, 26S-1 ↗Securities offering
- Aug 24, 26SCHEDULE 13G ↗Passive stake · L1 Capital Global Opportunities Master Fund, Ltd. · 10.0% · event on Aug 17, 26
- Aug 17, 268-K ↗Current report · Entered a material agreement
- Aug 17, 26424B5 ↗Securities offering
- Aug 13, 268-K ↗Current report · Results
- Aug 13, 2610-Q ↗Quarterly report
- Jul 24, 268-K ↗Current report · Communication to the market
- Jul 17, 268-K ↗Current report · Listing notice (8-K 3.01)
- Jul 13, 268-K ↗Current report · Communication to the market
- Jun 22, 268-K ↗Current report · Communication to the market
- Jun 12, 268-K ↗Current report · A senior executive left or was appointed
- Jun 11, 26Form 4 ↗Insider transaction
705 filings on record, the oldest from Mar 4, 14.
Listing the 25 most recent filings of the 705 on record.
146030
- Oct 2, 26Listing notice (8-K 3.01)8-K 3.01 ↗
- Aug 17, 26Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jul 17, 26Listing notice (8-K 3.01)nominal item 3.01: the filing covers another matter8-K 3.01 ↗
- Jun 12, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
3 sales of unregistered shares2026show all 3hide
- May 18, 26Sold unregistered shares8-K 3.02 ↗
- May 7, 26Sold unregistered shares8-K 3.02 ↗
- Apr 20, 26Sold unregistered shares8-K 3.02 ↗
- Apr 17, 26A senior executive left or was appointed8-K 5.02 ↗
4 sales of unregistered shares2026show all 4hide
- Apr 13, 26Sold unregistered shares8-K 3.02 ↗
- Mar 17, 26Sold unregistered shares8-K 3.02 ↗
- Mar 9, 26Sold unregistered shares8-K 3.02 ↗
- Jan 29, 26Sold unregistered shares+4 more in the same filing8-K 3.02 ↗
- Dec 1, 25A material agreement was terminated+2 more in the same filing8-K 1.02 ↗
- Jul 9, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Feb 14, 25Listing notice (8-K 3.01)8-K 3.01 ↗
3 material agreements entered2024show all 3hide
- Oct 23, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 21, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Apr 30, 24Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Jan 26, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
5 older filings not shown · The record reaches back to Jun 27, 14.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jan 19, 24Listing notice (8-K 3.01)8-K 3.01 ↗
- Jul 21, 23Listing notice (8-K 3.01)8-K 3.01 ↗
- Dec 16, 22Listing notice (8-K 3.01)8-K 3.01 ↗
- Dec 26, 19Listing notice (8-K 3.01)8-K 3.01 ↗
- Nov 22, 19Listing notice (8-K 3.01)8-K 3.01 ↗
- Jun 27, 19Listing notice (8-K 3.01)8-K 3.01 ↗
- Dec 6, 18Listing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
The full record holds 14 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- LAW CUSTODIAL INC.15.9%Sep 29, 25SCHEDULE 13G ↗
- L1 Capital Global Opportunities Master Fund, Ltd.10.0%Aug 17, 26SCHEDULE 13G ↗
- Lind Global Fund III LP5.7%Aug 17, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).
Stock compensation, tax and giftsshow the 5 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
The full record holds 5 transactions and goes back to Jan 24, 23.
Its sector and its market
Dare Bioscience Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Dare Bioscience Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Dare Bioscience Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 705 documents on file, from Mar 4, 2014 to Oct 6, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.